SFX by Ex Libris Inc.

Title:	Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease
Source:	Human Molecular Genetics [0964-6906] Cruts, M yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Cruts, M.. "Presenilin mutations in Alzheimer's disease." Human mutation 11.3 (1998): 183-190.
description	2.	Kauwe, John S K S. "Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation." Annals of neurology 61.5 (2007): 446-53.
description	3.	Saunders, A M M. "Association of apolipoprotein E allele [epsilon]4 with late-onset familial and sporadic Alzheimer's disease." Neurology 43.8 (1993): 1467-1472.
description	4.	Carlson, Christopher S S. "Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium." American journal of human genetics 74.1 (2003): 106-20.
description	5.	Theuns, J. "Promoter Mutations That Increase Amyloid Precursor-Protein Expression Are Associated with Alzheimer Disease." American journal of human genetics 78.6: 936-46.
description	6.	Corder, M A A. "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families." Science 261.5123 (1993): 921-3.
description	7.	Van Broeckhoven, C. "Molecular genetics of Alzheimer's disease." Annals of medicine 30.6 (1999): 560-5.
description	8.	Brunkan, A L L. "Presenilin function and gamma-secretase activity." Journal of neurochemistry 93.4: 769-792.
description	9.	Russo, C. "Presenilin-1 mutations in Alzheimer's disease." Nature 405.6786 (2000): 531-2.
description	10.	Citron, M. "Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice." Nature medicine 3.1 (1996): 67-72.
description	11.	Donnelly, P. "A haplotype map of the human genome." Nature 437.7063 (2005): 1299-1320.
description	12.	Zhang, J. "Proteomic discovery of CSF biomarkers for Alzheimer's disease." Annals of neurology 61.5 (2007): 497-8.
description	13.	Jayadev, S. "Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2." Brain 133.Pt 4 (2010): 1143-54.
description	14.	Blennow, K. "Longitudinal stability of CSF biomarkers in Alzheimer's disease." Neuroscience Letters 419.1 (2007): 18-22.
description	15.	Kauwe, John S.K. S. "Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life." Neuroscience Letters 438.2 (2008): 257-259.
description	16.	Wilson, Susan C. "Contact-promoting behavior, social development, and relationship with parents in sibling juvenile degus (Octodon degus)." Developmental psychobiology 15.3 (1982): 257-268.
description	17.	Hough, Christopher J J. "A guide to the genetics of psychiatric disease." Psychiatry 69.1 (2006): 1-20.
description	18.	Furukawa, K. "Presenilin-1 controls the growth and differentiation of endothelial progenitor cells through its beta-catenin-binding region." Cell biology international (2006): 239-43.
description	19.	Garai, K.. "Selective destabilization of soluble amyloid β oligomers by divalent metal ions." Biochemical and biophysical research communications 345.1: 210-215.
description	20.	Terruzzi, I. "Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?" Journal of endocrinological investigation 30.9 (2007): 747-753.